Verteporfin therapy for neovascular age-related macular degeneration in Indian eyes

Japanese Journal of Ophthalmology

Volumn 50, Issue 6, 2006, Pages 524-528

  Hussain, Nazimul ^a,b   Das, Taraprasad ^a   Khanna, Rohit ^b   Sumasri, Kallukuri ^a   Mohan Ram, Lakshmana Samudram ^a  

^a Smt Kanuri Santhamma Retina Vitreous Center   (India)

^b L V PRASAD EYE INSTITUTE   (India)

Author keywords

Age related macular degeneration; Choroidal neovascularization; Photodynamic therapy; Subfoveal; Verteporfin

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ADULT; AGED; ARTICLE; BACKACHE; CLINICAL ARTICLE; DETERIORATION; FEMALE; FOLLOW UP; HUMAN; INDIAN; MALE; MEDICAL RECORD; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

AGED; CHOROIDAL NEOVASCULARIZATION; FEMALE; HUMANS; INDIA; MACULAR DEGENERATION; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; PROSPECTIVE STUDIES; VISUAL ACUITY;

EID: 33845782933     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10384-006-0367-4     Document Type: Article

References (11)

1. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study group 1999 Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP Report No.1 Arch Ophthalmol 117 1329 1345
2. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group 2001 Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-TAP Report No. 2 Arch Ophthalmol 119 198 207
3. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group 2002 Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP Report NO. 3 Arch Ophthalmol 120 1443 1454
4. GS Rubin NM Bressler 2002 Effects of verteporfin therapy on contrast sensitivity: results from the treatment of age-related macular degeneration with photodynamic therapy (TAP) investigation-TAP Report No. 4 Retina 22 536 544
5. VerteporfIn in Photodynamic Therapy Study Group 2001 Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-Verteporfin in Photodynamic Therapy (TAP) Report No. 2 Am J Ophthalmol 131 541 560
6. Visudyne in Minimally Classic Choroidal Neovascularization Study Group 2005 Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial Arch Ophthalmol 123 448 457
7. Verteporfin Round Table Participants 2005 Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update Retina 25 119 134
8. N Hussain T Das U Vashist K Sumasri 2004 Verteporfin therapy for myopic choroidal neovascularisation in Indian eyes (one-year results) Indian J Ophthalmol 52 227 231
9. The Japanese Age-Related Macular Degeneration Trial (JAT) Study Group 2003 Japanese age-related macular degeneration trial: 1 year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration Am J Ophthalmol 136 1049 1061
10. N Hussain A Hussain S Natarajan 2005 Role of photodynamic therapy in polypoidal choroidal vasculopathy Indian J Ophthalmol 53 101 104
11. R Axer-Siegel R Ehrlich Y Yassur 2004 Photodynamic therapy for age-related macular degeneration in a clinical setting: visual results and angiographic patterns Am J Ophthalmol 137 258 264